Apolipoprotein B (APOB) retention in atherosclerotic intracranial arteries

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Low (LDL) and very low (VLDL) density lipoproteins retained in grossly normal and atherosclerotic human intracranial arteries have been quantitated using an electro-immunoassay directed against apolipoprotein B (apoB), the major protein of these two lipoprotein fractions. Buffer-homogenales of grossly normal arteries contained apoB amounts ranging from < 0.04 to 1.58 Mg/mg tissue dry weight, while those of atherosclerotic plaques gave values ranging from 0.80 to 3.9 g per mg tissue dry weight. These results were consistent with immunofluorescence studies localizing apoB in these arteries. Plaques also contained a remaining fraction of tightly-bound apoB as evidenced by positive immunofluorescence in sections of pellets from buffer homogenates. This was in contrast to the negative results from grossly normal arteries. These results would suggest that retention of apoB by intracranial arteries correlates positively with vessel lesions. Arterial apoB is present in both grossly normal regions and plaques in a loosely-bound form, possibly representing intact lipoprotein. ApoB is also present in a tightlybound form in plaques. © 1977 American Heart Association, Inc.

Cite

CITATION STYLE

APA

Hoff, H. F., Heideman, C. L., & Gaubatz, J. W. (1977). Apolipoprotein B (APOB) retention in atherosclerotic intracranial arteries. Stroke, 8(3), 366–370. https://doi.org/10.1161/01.STR.8.3.366

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free